Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
To determine if Iscar Quercus improves immune function and quality of life among patients with stage IV non-small cell lung cancer.
Non-Small Cell Lung Cancer
DRUG: Iscar Quercus|DRUG: Gemcitabine
To determine if Iscar improves immune function and quality of life.
RAndomized pilot study of supplemental Iscar in combination with Gemcitabine vs. Gemcitabine alone as second line treatment for advanced non-small cell lung cancer.